Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
PMID 35717735
Safety Considerations and Contraindications Who Should Avoid BPC-157 Contraindications : Active cancer diagnosis (due to angiogenic properties) Pregnancy or breastfeeding Severe cardiovascular disease Known hypersensitivity to peptides Drug Interactions BPC-157 has minimal known drug interactions but may potentially interact with: Anticoagulant medications (enhanced healing may affect clotting) Immunosuppressive drugs Other growth factors or healing peptides Medical Supervision Requirements Consult healthcare providers before starting BPC-157 if you have: Chronic medical conditions Recent surgical procedures Blood clotting disorders Current prescription medications Our Clinics Experience with BPC-157 Dosing Through extensive clinical experience with BPC-157 protocols, weve observed optimal healing results with 300 mcg daily split dosing for most applications
Chronic injuries typically show slower and less dramatic response to BPC-157 compared to acute injuries
Anxiety and cognitive effects often noticed first
MS analysis confirms that the synthesized peptide has the correct molecular weight 1,419.53 Da for the BPC-157 peptide verifying sequence integrity at the molecular level
